×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
9743 views

Modérateur : Pr Jean-Marc Classe

 

18:00
Qu’est-ce que la réponse pathologique complète et quels sous types sont concernés ?
Dr Anne Vincent-Salomon
 
18:15
A qui proposer de la CNA alors que la chirurgie première est faisable et quelles sont les perspectives ?
Dr Mahasti Saghatchian
 
18:30
A qui proposer une chimiothérapie néoadjuvante alors que l’intervention première est faisable et existe-t-il des perspectives de désescalade chirurgicale ?
Dr Marie Bannier
 
18:45
Quel impact sur la chirurgie axillaire ?
Pr Jean-Marc Classe
 
19:00 Débat/discussion - Réponses aux questions

 

Shooting date : 2021-12-21
Last update : 2022-03-09
1 comment
Join the Discussion
  • Bradley Sarnick Farel M. Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    0
    Days
    0
    Hours
    0
    Minutes
    0
    Seconds
    Tuesday, December 2nd 2025 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, December 2nd 2025 from 07am to 08:30am (GMT+1)
    San Francisco : Tuesday, December 2nd 2025 from 09am to 10:30am (GMT+1)
    New York : Tuesday, December 2nd 2025 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Tuesday, December 2nd 2025 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Tuesday, December 2nd 2025 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Tuesday, December 2nd 2025 from 06pm to 07:30pm (GMT+1)
    Istanbul : Tuesday, December 2nd 2025 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, December 2nd 2025 from 09pm to 10:30pm (GMT+1)
    Bangkok : Wednesday, December 3rd 2025 from 12am to 01:30am (GMT+1)
    Shanghai : Wednesday, December 3rd 2025 from 01am to 02:30am (GMT+1)
    Tokyo : Wednesday, December 3rd 2025 from 02am to 03:30am (GMT+1)
    Sydney : Wednesday, December 3rd 2025 from 03am to 04:30am (GMT+1)
    Wellington : Wednesday, December 3rd 2025 from 05am to 06:30am (GMT+1)

    Cancers du sein : nouveautés diagnostiques

    Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
    Honolulu : Wednesday, May 10th 2023 from 07am to 08:30am (GMT+2)
    San Francisco : Wednesday, May 10th 2023 from 10am to 11:30am (GMT+2)
    New York : Wednesday, May 10th 2023 from 01pm to 02:30pm (GMT+2)
    Buenos Aires : Wednesday, May 10th 2023 from 02pm to 03:30pm (GMT+2)
    Reykjavik : Wednesday, May 10th 2023 from 05pm to 06:30pm (GMT+2)
    London / Dublin : Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
    Paris / Berlin : Wednesday, May 10th 2023 from 07pm to 08:30pm (GMT+2)
    Istanbul : Wednesday, May 10th 2023 from 08pm to 09:30pm (GMT+2)
    Moscou / Dubaï : Wednesday, May 10th 2023 from 09pm to 10:30pm (GMT+2)
    Bangkok : Thursday, May 11th 2023 from 12am to 01:30am (GMT+2)
    Shanghai : Thursday, May 11th 2023 from 01am to 02:30am (GMT+2)
    Tokyo : Thursday, May 11th 2023 from 02am to 03:30am (GMT+2)
    Sydney : Thursday, May 11th 2023 from 04am to 05:30am (GMT+2)
    Wellington : Thursday, May 11th 2023 from 06am to 07:30am (GMT+2)

    Cancer du sein : actualités et essais en cours, vers où allons-nous ?

    Share
    Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Thursday, May 25th 2023 from 07:30am to 09am (GMT+2)
    San Francisco : Thursday, May 25th 2023 from 10:30am to 12pm (GMT+2)
    New York : Thursday, May 25th 2023 from 01:30pm to 03pm (GMT+2)
    Buenos Aires : Thursday, May 25th 2023 from 02:30pm to 04pm (GMT+2)
    Reykjavik : Thursday, May 25th 2023 from 05:30pm to 07pm (GMT+2)
    London / Dublin : Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
    Paris / Berlin : Thursday, May 25th 2023 from 07:30pm to 09pm (GMT+2)
    Istanbul : Thursday, May 25th 2023 from 08:30pm to 10pm (GMT+2)
    Moscou / Dubaï : Thursday, May 25th 2023 from 09:30pm to 11pm (GMT+2)
    Bangkok : Friday, May 26th 2023 from 12:30am to 02am (GMT+2)
    Shanghai : Friday, May 26th 2023 from 01:30am to 03am (GMT+2)
    Tokyo : Friday, May 26th 2023 from 02:30am to 04am (GMT+2)
    Sydney : Friday, May 26th 2023 from 04:30am to 06am (GMT+2)
    Wellington : Friday, May 26th 2023 from 06:30am to 08am (GMT+2)

    Cancer du sein RH+ : Quelles optimisations thérapeutiques en 2L métastatique ?

    Share
    Friday, February 9th 2024 from 05:30pm to 07pm (GMT+1)
    Honolulu : Friday, February 9th 2024 from 06:30am to 08am (GMT+1)
    San Francisco : Friday, February 9th 2024 from 08:30am to 10am (GMT+1)
    New York : Friday, February 9th 2024 from 11:30am to 01pm (GMT+1)
    Buenos Aires : Friday, February 9th 2024 from 01:30pm to 03pm (GMT+1)
    London / Dublin : Friday, February 9th 2024 from 04:30pm to 06pm (GMT+1)
    Paris / Berlin : Friday, February 9th 2024 from 05:30pm to 07pm (GMT+1)
    Istanbul : Friday, February 9th 2024 from 06:30pm to 08pm (GMT+1)
    Moscou / Dubaï : Friday, February 9th 2024 from 08:30pm to 10pm (GMT+1)
    Bangkok : Friday, February 9th 2024 from 11:30pm to 01am (GMT+1)
    Shanghai : Saturday, February 10th 2024 from 12:30am to 02am (GMT+1)
    Tokyo : Saturday, February 10th 2024 from 01:30am to 03am (GMT+1)
    Sydney : Saturday, February 10th 2024 from 02:30am to 04am (GMT+1)
    Wellington : Saturday, February 10th 2024 from 04:30am to 06am (GMT+1)

    Le réseau FEM-NET, position du problème pour les cancers du sein triples négatifs métastatiques

    Les webinars du réseau FEM-NET

    Share
    Scroll Up